Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Austar Lifesciences Ltd. ( (HK:6118) ) is now available.
Austar Lifesciences Ltd. has announced a significant turnaround in its financial performance, expecting a profit of RMB15 to 20 million for the year ending December 2024, compared to a loss of RMB113 million the previous year. This improvement is attributed to the absence of previous losses from certain subsidiaries, increased income from asset compensation in Shanghai, and savings from organizational optimization.
More about Austar Lifesciences Ltd.
Austar Lifesciences Ltd. is a company operating in the life sciences sector, focusing on providing various solutions and services relevant to this industry.
YTD Price Performance: -3.51%
Average Trading Volume: 115,169
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$281.9M
For an in-depth examination of 6118 stock, go to TipRanks’ Stock Analysis page.
